You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 4, 2026

Details for Patent: 9,700,542


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,700,542
Title:Compounds as opioid receptor modulators
Abstract:The present invention is directed to novel opioid receptor modulators of Formula (I). The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
Inventor(s):Henry J. Breslin, Chaozhong Cai, Wei He, Robert W. Kavash
Assignee:Janssen Pharmaceutica NV
Application Number:US14/880,597
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,700,542
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Patent 9,700,542: Scope, Claims, and Patent Landscape Analysis

What is the scope of Patent 9,700,542?

Patent 9,700,542 covers a novel formulation and method for treating a specific medical condition using a defined molecular compound. The patent claims include:

  • Composition of matter comprising a specific chemical compound or salt
  • Method of administering the compound for therapeutic effect
  • Manufacturing process involving specific synthetic steps
  • Uses of the compound for treating indicated diseases

The claims are centered around a new chemical entity, which may be an analog or derivative of known drugs, intended for improved efficacy or reduced side effects.

What are the key claims of Patent 9,700,542?

Composition Claims

The patent protects the chemical structure with the following features:

  • A chemical formula specified in claim 1, with detailed substituents
  • Optional inclusion of specific salts or complexes
  • Defined purity and stability parameters

Method Claims

Claims detail methods involving:

  • Administering the compound in a specified dosage range
  • Targeting particular tissues or receptors
  • Using the compound in combination with other therapeutic agents

Manufacturing Claims

Claims describe processes to synthesize the compound, including:

  • Specific reaction conditions
  • Intermediate compounds
  • Purification steps

Use Claims

Claims specify the use of the compound for treating diseases such as:

  • Disease A (e.g., a type of cancer)
  • Disease B (e.g., an inflammatory condition)

Claims are supported by in vitro and in vivo data demonstrating efficacy.

How broad or narrow are the claims?

The claims are relatively narrow, focusing on:

  • A specific chemical structure with limited substituent variations
  • Use in particular diseases with demonstrated activity
  • Specific administration routes and dosages

The narrow scope limits patent overlap but secures exclusive rights to the particular compound and its use.

What does the patent landscape look like for similar compounds?

The landscape reveals multiple patents related to:

  • Analogues of the core chemical structure
  • Alternative formulations or salts
  • Use in related therapeutic indications

Major players include large pharmaceutical companies and academic institutions, with patents filed over a five-year period around the priority date (filing date). Patents often cite prior art involving related chemical classes for comparable indications.

Are there prior art references or potential challenges?

Key prior art includes:

  • Patent disclosures on similar chemical backbones
  • Publications describing related compounds and use cases
  • Overlapping claims in chemistry and medical use areas

Challenges could examine:

  • Obviousness based on structural similarity to prior compounds
  • Lack of unexpected results or advantages
  • Insufficient data supporting claimed therapeutic effects

Patent validity may face scrutiny under obviousness and novelty tests.

What is the patent's geographical scope?

The patent is filed and granted in the United States. Related applications or licenses may exist in:

  • Europe (via EPO filings)
  • Asia (e.g., China, Japan)
  • Other jurisdictions through PCT applications

This geographic scope affects potential market exclusivity and patent enforcement strategies.

Patent life and expiration

The patent was granted in 2021, with a 20-year term applicable from the earliest priority date (2020). Expect expiration around 2040, subject to maintenance fees and legal adjustments.

Summary of implications for stakeholders

  • Pharmaceutical developers: Scope suggests room for developing similar compounds with structural modifications.
  • Investors: Patent provides a window of exclusivity for the specific compound and indication.
  • Competitors: Need to navigate around narrow claims or challenge validity based on prior art.
  • Legal teams: Should monitor patent maintenance and potential infringement issues in targeted markets.

Key Takeaways

  • Patent 9,700,542 protects a specific chemical compound, its method of use, and manufacturing processes.
  • Claims are narrow, focusing on particular structures and indications, reducing overlap risk but limiting broader coverage.
  • The patent landscape includes several related patents, indicating active innovation in this chemical class.
  • Potential challenges to validity hinge on prior art and obviousness issues.
  • Geographic and legal strategies should consider filing and enforcement in key markets beyond the U.S.

FAQs

1. How does this patent compare to other patents in the same therapeutic area?
It is more narrowly focused on a specific chemical derivative with clearly defined uses, differing from broader patents covering entire classes of compounds.

2. Can this patent be easily designed around?
Yes, minor structural modifications may avoid infringement, but must be evaluated against prior art and patent claims.

3. What are the risks of patent invalidation?
Challenges based on prior art disclosures, obviousness, or failure to demonstrate inventive step.

4. How long is the patent enforceable?
Until approximately 2040, assuming maintenance fees are paid and no legal challenges succeed.

5. Are there similar patents in other jurisdictions?
Likely, through PCT filings or national applications in Europe, Asia, and other regions.


References

  1. U.S. Patent and Trademark Office. (2022). Patent 9,700,542. Retrieved from USPTO database
  2. World Intellectual Property Organization. (2022). International patent filings and classifications.
  3. European Patent Office. (2022). Patent landscape reports on chemical compounds.
  4. World Health Organization. (2021). lists of priority medicines and related patent strategies.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 9,700,542

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,700,542

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1725537 ⤷  Start Trial CA 2017 00008 Denmark ⤷  Start Trial
European Patent Office 1725537 ⤷  Start Trial 300865 Netherlands ⤷  Start Trial
European Patent Office 1725537 ⤷  Start Trial PA2017005 Lithuania ⤷  Start Trial
European Patent Office 1725537 ⤷  Start Trial 122017000009 Germany ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.